- Home
- NHTC vs TNXP Comparison
NHTC vs TNXP Comparison
Compare NHTC & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- TNXP
- Stock Information
- Founded
- NHTC 1988
- TNXP 2007
- Country
- NHTC Hong Kong
- TNXP United States
- Employees
- NHTC N/A
- TNXP N/A
- Industry
- NHTC Diversified Commercial Services
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- NHTC Miscellaneous
- TNXP Health Care
- Exchange
- NHTC Nasdaq
- TNXP Nasdaq
- Market Cap
- NHTC 48.8M
- TNXP 57.9M
- IPO Year
- NHTC 1995
- TNXP N/A
- Fundamental
- Price
- NHTC $4.79
- TNXP $0.24
- Analyst Decision
- NHTC
- TNXP Strong Buy
- Analyst Count
- NHTC 0
- TNXP 2
- Target Price
- NHTC N/A
- TNXP $53.50
- AVG Volume (30 Days)
- NHTC 17.5K
- TNXP 134.8M
- Earning Date
- NHTC 02-05-2025
- TNXP 11-12-2024
- Dividend Yield
- NHTC 16.70%
- TNXP N/A
- EPS Growth
- NHTC 72.15
- TNXP N/A
- EPS
- NHTC 0.06
- TNXP N/A
- Revenue
- NHTC $43,054,000.00
- TNXP $11,291,000.00
- Revenue This Year
- NHTC N/A
- TNXP $64.71
- Revenue Next Year
- NHTC N/A
- TNXP $24.49
- P/E Ratio
- NHTC $79.91
- TNXP N/A
- Revenue Growth
- NHTC N/A
- TNXP 183.05
- 52 Week Low
- NHTC $4.02
- TNXP $0.12
- 52 Week High
- NHTC $7.40
- TNXP $12.48
- Technical
- Relative Strength Index (RSI)
- NHTC 54.01
- TNXP 43.95
- Support Level
- NHTC $4.56
- TNXP $0.22
- Resistance Level
- NHTC $4.74
- TNXP $0.26
- Average True Range (ATR)
- NHTC 0.21
- TNXP 0.04
- MACD
- NHTC 0.06
- TNXP -0.02
- Stochastic Oscillator
- NHTC 75.00
- TNXP 7.38
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.